Treat DVT with low molecular weight heparin.
Each year, deep vein thrombosis (DVT) affects two million Americans, and pulmonary embolism (PE) affects 600,000. Traditional treatment requires hospitalizationto receive continuous intravenous unfractionated heparin (UFH), which has substantial pharmacokinetic limitations. Low molecular weight hepa...
| Publicado en: | Nurse Practitioner Vol. 28; no. 10; pp. 22 - 28 |
|---|---|
| Autores principales: | , |
| Formato: | care plan CEU exam questions Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Oct2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106699306&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106699306 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 03611817 39E jtl: Nurse Practitioner issn: 03611817 maglogo: N pubinfo: dt: Oct2003 vid: 28 iid: 10 pid: 5086 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 106699306 106699306 2004030748 10.1097/00006205-200310000-00010 NLM14560128 106699306 ppf: 22 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Treat DVT with low molecular weight heparin. aug: au: Nadeau C Varrone J affil: Family Nurse Practitioner, Certified Anticoagulation Care Provider, NYU Hospitals Center Anticoagulation Management Service sug: subj: Heparin, Low-Molecular-Weight Therapeutic Use Pulmonary Embolism Drug Therapy Venous Thrombosis Drug Therapy Ambulatory Care Education, Continuing (Credit) Heparin, Low-Molecular-Weight Contraindications Heparin, Low-Molecular-Weight Economics Heparin, Low-Molecular-Weight Pharmacokinetics Nurse Practitioners Education Patient Education Pulmonary Embolism Prevention and Control Venous Thrombosis Prevention and Control ab: Each year, deep vein thrombosis (DVT) affects two million Americans, and pulmonary embolism (PE) affects 600,000. Traditional treatment requires hospitalizationto receive continuous intravenous unfractionated heparin (UFH), which has substantial pharmacokinetic limitations. Low molecular weight heparins have overcome many of these limitations, resulting in a predictable anticoagulant response without the need for laboratory monitoring or dosage adjustment. pubtype: Academic Journal doctype: care plan CEU exam questions Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|